​
​

Aytu BioPharma Ownership | Who Owns Aytu BioPharma?

OverviewForecastRevenueFinancialsChartTranscripts

Aytu BioPharma Ownership Summary

Aytu BioPharma is owned by 0.15% institutional investors, and 99.85% retail investors. Fidelity Extended Market Index is the top mutual fund, with 0.55% of its assets in Aytu BioPharma shares.

AYTU Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAytu BioPharma0.15%-99.85%
SectorHealthcare Stocks 46.98%7.90%45.12%
IndustrySpecialty & Generic Drug Manufacturers Stocks34.80%9.10%56.10%

Institutional Shareholders

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20231-96.88%5,579-99.93%-0.10%--100.00%--100.00%
Dec 31, 202232-8.57%7,742,624-8.93%126.66%15-11.76%9-10.00%
Sep 30, 20223529.63%8,501,749142.28%1314.36%1713.33%1042.86%
Jun 30, 202227-3,509,030-35.21%92.93%1566.67%7-41.67%
Mar 31, 202227-27.03%5,415,93548.63%189.58%9-35.71%12-14.29%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Extended Market Index34.02K0.55%4.12K
Vanguard Institutional Extnd Mkt Idx Tr27.89K0.45%-
DFA US Targeted Value I8.66K0.14%2.50K
Fidelity Series Total Market Index8.05K0.13%4.94K
NT Ext Equity Mkt Idx Fd - L6.31K0.10%-
Northern Trust Extended Eq Market Idx6.31K0.10%-
Dimensional US Sustainability Core 1 ETF3.85K0.06%-
BlackRock Extended Equity Market K3.56K0.06%-2.00
Dimensional US Targeted Value ETF3.38K0.05%-
DFA US Micro Cap I3.23K0.05%-

Recent Insider Transactions

DateNameRoleActivityValue
Jun 16, 2023PYSZCZYMUKA GREG Chief Commerical OfficerBuy$22.43K
Jun 14, 2023Disbrow Joshua R. Chief Executive OfficerBuy$26.08K
Dec 19, 2022Disbrow Joshua R. Chief Executive OfficerBuy$25.05K
Dec 19, 2022PYSZCZYMUKA GREG Chief Commercial OfficerBuy$24.48K
Nov 18, 2022Oki Mark K Chief Financial OfficerBuy$20.70K

Insider Transactions Trends

DateBuySell
2024 Q4--
2024 Q3--
2024 Q2--
2024 Q1--
2023 Q4--

AYTU Ownership FAQ

Who Owns Aytu BioPharma?

Aytu BioPharma shareholders are primarily institutional investors at 0.15%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Aytu BioPharma's industry, Specialty & Generic Drug Manufacturers Stocks, is 34.80%, which Aytu BioPharma falls below.

Does Blackrock own Aytu BioPharma?

BlackRock is not among the top 10 institutional shareholders of Aytu BioPharma.

Who is the top mutual fund holder of Aytu BioPharma shares?

Fidelity Extended Market Index is the top mutual fund holder of Aytu BioPharma shares, with 0.55% of its total shares outstanding invested in 34.02K Aytu BioPharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools